Takeda Pharmaceutical Company (4502) EGM 2024 summary

Opening remarks and agenda

• CEO opened the meeting, introduced key executives, and explained the agenda, including reports, Q&A, and voting procedures.

• The meeting was live-streamed, and simultaneous interpretation was provided for non-Japanese speakers.

Specific resolutions to be voted on

• Appropriation of surplus: proposed year-end dividend of JPY 94 per share, effective June 27, 2024.

• Election of 10 directors (non-ASC members), including seven external candidates.

• Election of four directors (ASC members), all external.

• Payment of bonuses up to JPY 5 million to two directors (excluding external and overseas directors).

Board and executive committee updates

• Milano Furuta introduced as new CFO and proposed as internal director.

• Three new executive team members acknowledged; board now includes 14 members, 11 of whom are independent external directors.

• Committees (Audit, Compensation, Nomination) are chaired and staffed entirely by external directors.